March 19, 2008
Visiogen’s Interactive Website Wins Golden Advocate Award
Company wins Gold in the Category of Website Design
November 7, 2007
Visiogen Achieves Full Enrollment of Synchrony® Subjects in its Phase III Clinical Trial
Study Examining the Efficacy of the Synchrony 3-Dimensional Dual Optic Accommodating Intraocular Lens Has Reached Critical Recruitment Goal
October 24, 2007
Visiogen, Inc. Launches New Website
New Interactive Educational Website is the Online Home of the Synchrony® 3-Dimensional Dual Optic Accommodating Intraocular Lens
May 17, 2007
Visiogen, Inc. Recognized at American Society of Cataract and Refractive Surgery Symposium with Two Best of Session Papers
Findings Further Support the Validity of the Synchrony® Dual Optic Accommodating Intraocular Lens
February 28, 2007
Visiogen, Inc. Signs Significant Financing Agreement
Company Raises $24 Million, Further Supporting its Mission and the Validity of the Synchrony® Dual Optic Accommodating Intraocular Lens.
January 17, 2007
Visiogen, Inc. Receives FDA Approval to Expand its U.S. Clinical Trial
Expansion of Trial Will Allow Researchers to Further Validate Safety and Effectiveness of the Investigational Synchrony® Dual Optic Accommodating Intraocular Lens.
December 4, 2006
Presentations at American Academy of Ophthalmology Annual Meeting
Feature Visiogen, Inc.—Favorable Reviews by Industry Clinicians Further Endorse Viability of Visiogen’s Synchrony®.
October 18, 2006
Encouraging Clinical Data on Visiogen’s Synchrony® Dual Optic IOL Presented at European Eye Care Conference
Strong Reception at Prestigious European Congress Bodes Well for Visiogen’s Synchrony®
July 10, 2006
Visiogen’s Barbara Niksch to Serve as Industry Representative
on the FDA’s Ophthalmic Devices Panel of the Medical Devices Advisory Committee
June 23, 2006
Visiogen, Inc. Receives European CE Mark For Its Dual-Optic Accommodating Intraocular Lens
Visiogen, Inc. of Irvine, California, today announced that it has received approval in Europe for its dual-optic accommodating intraocular lens (AIOL).

Kate Jennings
Director of Public Relations
Maricich Communications
949-223-6455
kate@maricich.com

Dan McWard
Vice President, Marketing
Visiogen
949-341-0700, x-246
dmcward@visiogen.com